CURE GM1 INCORPORATED (EIN 473154419) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2014

Legal Domicile

Principal Officer

CHRISTINE M WAGGONER

Phone

5109223311

Tax Period

2023-01-01 to 2023-12-31

CURE GM1 INCORPORATED, founded in 2014, is a small nonprofit in the Medical Research sector that reported $534K in total revenue in fiscal year 2023. Expenses of $689K exceeded revenue, resulting in a 29% operating deficit.

Mission

THE PURPOSE OF THE ORGANIZATION IS TO RAISE FUNDS FOR MEDICAL RESEARCH FOR A RARE DISEASE CALLED GM1 GANGLIOSIDOSISTHAT HAS NO CURE OR TREATMENT OTHER THAN COMFORT MEASURES AND SYMPTOM MANAGEMENT. PROMISING RESEARCH EXISTS, BUT LACKS FUNDING. THE ORGANIZATION HOPE TO UNITE FAMILIES OF THOSE WHO SUFFER FROM THIS DISEASE AND THEIR SUPPORTERS BY FUNDRAISING FOR A CURE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $443,512

Program Service Revenue $0

Investment Income $90,208

Other Revenue $0

TOTAL REVENUE $533,720

Expense Breakdown

Grants Paid $0

Salaries & Benefits $47,447

Fundraising Expenses $4,335

Program Expenses $657,501

Other Expenses $641,851

TOTAL EXPENSES $689,298

Year-over-Year Comparison

	2023	2022	Change
Revenue	$533,720	$521,967	+0.0%
Expenses	$689,298	$219,320	+2.1%
Net Income	$-155,578	$302,647	-1.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
VANESSA RANGEL MILLER	DIRECTOR	5.00	Director	$0	$0	$0
KYLIE HARRISON	SECRETARY	1.00	Officer Director	$0	$0	$0
DAVID LAW	DIRECTOR	0.00	Director	$0	$0	$0
BINGYUNE CHEN	DIRECTOR	0.00	Director	$0	$0	$0
RAFAEL ESCANDON	DIRECTOR	5.00	Director	$0	$0	$0
CHRISTINE M WAGGONER	CEO	15.00	Officer	$0	$0	$0
DAWN BLESSING	VICE PRESIDENT	5.00	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$533,720	$689,298	$3,216,016	$-155,578
2022	$521,967	$219,320	$3,215,700	$302,647
2021	$549,261	$142,807	$3,273,591	$406,454
2020	$617,781	$30,608	$2,781,750	$587,173
2019	$373,224	$79,883	$2,194,622	$293,341
2019	$373,224	$79,883	$2,194,622	$293,341
2018	$373,562	$125,916	$1,901,236	$247,646

CURE GM1 INCORPORATED